Concepedia

Publication | Closed Access

DISPOSITION OF BASILIXIMAB, AN INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY, IN RECIPIENTS OF MISMATCHED CADAVER RENAL ALLOGRAFTS1

DOI

126

Citations

4

References

1997

Year

John M. Kovarik, P. Wolf, J.M. Cisterne, G. Mourad, Yvon Lebranchu, P Lang, B. Bourbigot, Diego Cantarovich, Dominique Girault, Christophe Gerbeau,
Transplantation

Abstract

Total basiliximab doses of 40-60 mg were well tolerated, nonimmunogenic, and estimated to provide immunoprophylaxis to cover the first posttransplant month.

References

YearCitations

Page 1